|
Event Registration for Industry Professionals | Molecular Tumor Board: Integrating Biomarker Analyses into Clinical Decision-Making Regarding the Use of Immune Checkpoint Inhibitors in Cancer Treatment — April 3, 2017, Washington, DCThis activity is intended for medical oncologists, hematologists, surgeons, radiation oncologists, oncology nurses and other healthcare professionals involved in basic, translational and clinical cancer research or treatment. Thank you for your interest in our CME program. At this time online preregistration is limited to clinicians in practice. Onsite registration will be open starting at 6:15 PM (local time) on Monday, April 3, 2017. If you are interested in attending, please visit our registration desk located outside Independence Ballroom A (Level 5B) of the Grand Hyatt Washington hotel (1000 H St NW, Washington, DC 20001). |